Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Agios Pharmaceuticals, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 12:07 PM	f70e5378
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	ea7255f5
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 12:07 PM	b94f8c2f
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	0213800c
crunchbase profile	general	Nov 27, 2024 2:34 PM	bd989824
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general	Dec 4, 2024 2:13 PM	83e19ec7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AGIOS

Agios Pharmaceuticals, Inc.

Last Close

55.54

22/11 21:00

Market Cap

2.47B

Beta: -

Volume Today

419.15K

Avg: -